Also, our current observation indicates that the c-Myc-ODC axis has an essential role in JAK2 (V617F)-induced tumorigenesis, and suggests that DFMO would also be useful as an anti-cancer drug for MPNs. This evidence concerns the gene JAK2 and cancer.